ArticleBritish journal of haematology2019

Comparison of effects of midostaurin, crenolanib, quizartinib, gilteritinib, sorafenib and BLU-285 on oncogenic mutants of KIT, CBL and FLT3 in haematological malignancies.

Ellen Weisberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.